Cite
APA Citation
Panaccione, R., Sandborn, W. J., D'Haens, G., Wolf, D. C., Berg, S., Maa, J., Petersson, J., & Robinson, A. M. (n.d.). clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials. Journal of Crohn's and colitis, 12, 930–938. http://access.bl.uk/ark:/81055/vdc_100095513043.0x00000d